跳至主要内容
临床试验/NCT05191212
NCT05191212已完成不适用

Real-time Lymphatic Channel Visualization Compared With Conventional Cervical Indocyanine Green Injection for Sentinel Lymph Node Mapping in Early-stage Endometrial Cancer

Bakirkoy Dr. Sadi Konuk Research and Training Hospital2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年7月13日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
2
主要终点
Bilateral sentinel lymph node detection rate

研究概览

简要总结

Endometrial cancer is the most common malignancy of the female genital tract. Standard treatment for early-stage disease includes hysterectomy, bilateral salpingo-oophorectomy, and lymph node assessment. Sentinel lymph node (SLN) mapping with indocyanine green (ICG) has become widely used as an alternative to systematic lymphadenectomy due to lower morbidity and high detection rates.

This randomized clinical trial was designed to compare conventional cervical ICG injection with a modified technique, in which injection is continued until real-time lymphatic channels are visualized intraoperatively, for bilateral SLN detection in patients with clinical early-stage endometrial cancer undergoing robotic surgery.

详细描述

Primary treatment of clinical early-stage endometrial cancer consists of total hysterectomy, bilateral salpingo-oophorectomy, and lymph node assessment for staging. Sentinel lymph node (SLN) biopsy using indocyanine green (ICG) has been recommended in international guidelines as an alternative to systematic lymphadenectomy.

Conventional cervical ICG injection achieves bilateral SLN detection rates of approximately 73-75%. Re-injection may increase detection but prolongs the procedure. To optimize this approach, the investigators developed a modified technique in which ICG injection is continued until real-time lymphatic channels are visualized intraoperatively using the Firefly fluorescence mode of the robotic system.

The trial was designed as a prospective, randomized study comparing the conventional method with the modified technique in patients with clinical early-stage endometrial cancer undergoing robotic surgery. Participants were randomized in a 1:1 ratio to either the conventional cervical ICG injection group or the real-time lymphatic channel-guided ICG injection group. Randomization was performed using a computer-generated random sequence.

Initially, a sample size of 24 participants per group was planned, assuming bilateral detection rates of 75% (conventional) and 99% (modified). During the course of the study, the observed rates were 82.5% and 97.5%, respectively. A revised power analysis indicated the need for 40 participants per group, and the protocol was amended accordingly.

The study was completed with 40 participants in each group. The primary outcome was the rate of bilateral SLN detection. Secondary outcomes included operative parameters and perioperative complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

盲法说明

Not applicable. This is an open-label surgical trial; no parties were masked.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with clinical stage 1-2 endometrial cancer ASA 1-3 patients. Ability to provide written informed consent

排除标准

  • Patients with clinical stage 3-4 endometrial cancer Patients who are not suitable for robotic surgery due to their comorbidities (such as glaucoma, COPD, asthma) ASA 4-5 patients. Patients unable or unwilling to provide informed consent

结局指标

主要结局

Bilateral sentinel lymph node detection rate

时间窗: Intraoperative (during surgery)

Proportion of patients in whom sentinel lymph nodes are successfully identified bilaterally.

次要结局

  • Unilateral Sentinel Lymph Node Detection Rate(Intraoperative)
  • Overall Sentinel Lymph Node Detection Rate (bilateral + unilateral)(Intraoperative)
  • Operative Time(From skin incision to skin closure)
  • Time Required for Bilateral Sentinel Lymph Node Removal(Intraoperative (measured during surgery))
  • Estimated Blood Loss(During surgery)
  • Intraoperative and Postoperative Complications(Up to 30 days after surgery)

研究者

发起方
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Gokhan Demirayak, MD

Assoc. Professor of Gynecologic Oncology, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

研究点 (2)

Loading locations...

相似试验